WallStreetZenWallStreetZen

NASDAQ: ONCO
Onconetix Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Onconetix earnings were -$10.2M for the trailing 12 months ending Jun 30, 2026, with -99.5% growth year over year. The latest ONCO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.9M, down 32% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ONCO reported annual earnings of -$15.5M, with -73.6% growth. The next ONCO earnings date is Nov 12, 2026.

ONCO past earnings growth

How has ONCO's earnings growth performed historically?

Company
-99.48%
Industry
18.03%
Market
93.54%
ONCO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ONCO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ONCO earnings history

Current Revenue
$645.8k
Current Earnings
-$10.2M
Current Profit Margin
-1,578.8%

ONCO Return on Equity

Current Company
-92%
Current Industry
-13.6%
Current Market
30.9%
ONCO's Return on Equity (-92%)... subscribe to Premium to read more.
High Return on Equity Performance

ONCO Return on Assets

Current Company
-53.8%
Current Industry
-10.3%
ONCO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ONCO announces earnings.

ONCO Return on Capital Employed

Current Company
-73.31%
Current Industry
-7%
ONCO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONCO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ONCO-$9.87M-$10.20M-99.48%$248.72
SLXN-$14.12M-$13.96MN/A-$28.43
GOVX-$20.37M-$20.43MN/A-$9.59
MTNB-$6.27M-$7.31MN/A-$1.17
GNPX-$16.50M-$16.50MN/A-$10.50
View Top Biotech Stocks

ONCO earnings dates

Next earnings date
Nov 12, 2026

Onconetix Earnings Reports & History FAQ

What were Onconetix's earnings last quarter?

On ONCO's earnings call on Aug 13, 2026, Onconetix (NASDAQ: ONCO) reported Q2 2026 earnings per share (EPS) of -$1.28, up 99.46% year over year. Total ONCO earnings for the quarter were -$2.87 million. In the same quarter last year, Onconetix's earnings per share (EPS) was -$237.91.

If you're new to stock investing, here's how to buy Onconetix stock.

When does Onconetix report earnings?

The next ONCO earnings call is Nov 12, 2026. Add ONCO to your watchlist to be reminded of Onconetix's next earnings date.

What was ONCO's earnings growth in the past year?

As of Onconetix's earnings date in Aug 13, 2026, Onconetix's earnings has grown -99.48% year over year. This is 117.51 percentage points lower than the US Biotechnology industry earnings growth rate of 18.03%. ONCO earnings in the past year totalled -$10.20 million.

Is Onconetix profitable or losing money?

As of the last Onconetix earnings report, Onconetix is currently losing money. Onconetix's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$10.20 million, a 76.92% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.